Skip to main content
. Author manuscript; available in PMC: 2011 Oct 10.
Published in final edited form as: Eur J Pharmacol. 2010 Jun 30;644(1-3):10–16. doi: 10.1016/j.ejphar.2010.06.023

Table 1.

Inhibition by ADP and expression levels of wild-type and mutant P2Y12 receptor constructs expressed in CHO-K1 cells.

Construct Max. inhibition by ADP (% of control) IC50 ADP(μM) Expression levels (% of wild-type)
Wild-type 85.37 ± 2.14 (3) 0.25±0.04 100 ± 1.09 (14)
F104S 77.7 ± 1.12 (3) 0.06±0.01a 103.21 ± 1.78 (12)
Y109S 31.96 ± 0.15b (3) 0.17±0.09 120.87 ± 0.7 (13)
F198P 40.37 ± 10.64b(3) 0.15±0.05 143.46 ± 0.75 (15)
H253S 62.21 ± 1.93 (3) 0.35±0.21 105.39 ± 0.99 (24)
R256T 79.53 ± 4.83 (3) 0.29±0.05 123.28 ± 0.75 (26)
R256Q 75.32 ± 6.91 (3) 0.57±0.03a 106.19 ± 0.72 (11)
R265W 58.01 ± 3.08a (3) 0.45±0.21 87.38 ± 0.90 (8)
R256QR265W 56.68 ± 6.32a (3) 6.46±0.19b 148.85 ± 0.81 (20)
S288P 68.89 ± 6.24 (3) 0.04±0.01a 120.17 ± 0.97 (16)

Mean ± S.E.M. of (n) experiments.

a

P<0.01,

b

P<0.001, significant differences vs. values determined at wild-type P2Y12 receptors (student t-test). Expression levels were estimated by averaging fluorescence values from the membrane regions of cells after immunofluorescence staining with a monoclonal antibody against the HA-tag.